Showing results (21-30 of 94) with videos related to
Sort By:
Pageof 10
Pediatric Blood & Cancer|March 24, 2026
Cognitive Functioning in Vorinostat-Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell TransplantKristen L Votruba, Michelle Rozwadowski, Thomas Braun, et al.American Journal of Hematology|July 1, 2026
Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" TrialBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.Transfusion Medicine Reviews|December 3, 2014
National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: scientific opportunities in extracorporeal photopheresisNora Ratcliffe, Nancy M Dunbar, Jill Adamski, et al.Contemporary Clinical Trials|July 22, 2024
Study Protocol: Predicting the Quality of Response to Specific Treatments (PQRST) in Chronic Graft-versus-Host DiseaseBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.Blood|May 27, 2008
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survivalSung W Choi, Carrie L Kitko, Thomas Braun, et al.Blood|November 29, 2007
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host diseaseJohn E Levine, Sophie Paczesny, Shin Mineishi, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical TrialCarrie L Kitko, Thomas Braun, Daniel R Couriel, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host DiseaseHolly K Miller, Thomas M Braun, Terri Stillwell, et al.JAMA Dermatology|January 21, 2026
Discordance in Treatment Response Assessment Between Clinicians and Patients With Skin Chronic Graft-vs-Host DiseaseVarshini Babu, Daniel B Shin, Lynn Onstad, et al.Transplantation and Cellular Therapy|May 23, 2025
NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 UpdateStephanie J Lee, Kirsten M Williams, Stefanie Sarantopoulos, et al.Pageof 10